A San Diego biotech looking to double up on the power of antibody-drug conjugates with fewer toxicities has patched together a $137 million Series B from a group of blue-chip investors.
The seven-employee startup, called …
Plus, news about Novavax, ReAlta and AtaiBeckley: Merck adjusts China vaccine supply deal: The company and its distribution partner Zhifei have tweaked their agreement as
Gilead Sciences has dedicated around $11 billion so far this year to three acquisitions meant to bolster its pipelines in cancer and immunology. The pharma
After a flashy debut during the height of the Covid-19 pandemic, Talkspace, like many other virtual mental health companies, struggled to keep the momentum going.
Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a “destruction in shareholder value.”
A startup developing a one-time treatment that is intended to rewind the clock on dying cells announced a major influx of funding. Life Biosciences, a
A San Diego biotech looking to double up on the power of antibody-drug conjugates with fewer toxicities has patched together a $137 million Series B from a group of blue-chip investors.
The seven-employee startup, called …